Optic neuropathy after COVID-19 vaccination: a report of two cases.

Purpose: We report two cases of optic nerve pathology after the administration of the Pfizer-BioNTech and AstraZeneca-Oxford COVID-19 vaccines, respectively, and describe the implications for management of post-vaccination central nervous system (CNS) inflammation.

Case Reports: A 69-year-old woman presented with bilateral optic nerve head oedema, 16 days after the second dose of the Pfizer-BioNTech vaccine. She was diagnosed with post-vaccination CNS inflammatory syndrome and was treated for five days with intravenous methylprednisolone at a dose of 1 gram per day.

Improved Automatic Grading of Diabetic Retinopathy Using Deep Learning and Principal Component Analysis.

Diabetic retinopathy (DR) is one of the most common chronic diseases around the world. Early screening and diagnosis of DR patients through retinal fundus is always preferred. However, image screening and diagnosis is a highly time-consuming task for clinicians.

Consequences of COVID-19 on Uveitis Patients from Their Own Perspective: A Questionnaire-based Study.

Purpose: Given their immunocompromised status, uveitis patients should be particularly careful during the COVID-19 pandemic. Treatment compliance and adherence are among the most important patient-related determinants of treatment success.To assess the effect of the COVID-19 pandemic on the management of uveitis patients from their own perspective.

Comparison between Latanoprost, Travoprost, and Tafluprost in reducing intraocular pressure fluctuations in patients with glaucoma.

Purpose: To compare the efficacies of latanoprost 0.005%, travoprost 0.004%, and tafluprost 0.

Spectral-Domain Optical Coherence Tomography of Preclinical Chloroquine Maculopathy in Egyptian Rheumatoid Arthritis Patients.

Purpose. To evaluate the role of spectral-domain optical coherence tomography (SD-OCT) in early detection of Chloroquine maculopathy in rheumatoid arthritis (RA) patients. Methods.